#1 Clinical Trials Search in Europe

Fluticasone

This article summarizes several clinical trials investigating the use of fluticasone, a corticosteroid medication, in treating asthma and allergic rhinitis. The studies examine different formulations and combinations of fluticasone compared to other treatments, evaluating factors like efficacy, safety, and bioavailability in both adult and pediatric patients.

Table of Contents

What is Fluticasone?

Fluticasone is a medication that belongs to a class of drugs called corticosteroids. It is widely used to treat various respiratory conditions, particularly asthma and allergic rhinitis (hay fever)[1]. Fluticasone is known by several brand names, including Flonase, Flovent, and Arnuity[2]. This medication works by reducing inflammation in the airways, making it easier for patients to breathe.

Conditions Treated by Fluticasone

Fluticasone is primarily used to treat the following conditions:

  • Asthma: A chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties[3]
  • Allergic Rhinitis: Also known as hay fever, this condition causes inflammation in the nasal passages due to allergies[4]
  • Seasonal and Perennial Allergies: Allergies that occur during specific seasons or throughout the year[4]

How Fluticasone Works

Fluticasone works by reducing inflammation in the airways. When inhaled or sprayed into the nose, it helps to:

  • Decrease swelling in the nasal passages and lungs
  • Reduce mucus production
  • Alleviate symptoms such as sneezing, runny nose, and difficulty breathing

By targeting inflammation, fluticasone helps to improve overall respiratory function and provides relief from asthma and allergy symptoms[2].

Forms and Dosages

Fluticasone is available in several forms, including:

  • Nasal Spray: Used for allergic rhinitis, typically administered once or twice daily[1]
  • Inhaler: Used for asthma, available as a metered-dose inhaler (MDI) or dry powder inhaler (DPI)[2]
  • Diskus: A dry powder inhaler device used for asthma treatment[2]

Dosages can vary depending on the condition being treated, the severity of symptoms, and the specific product being used. It’s essential to follow your healthcare provider’s instructions carefully.

Combination Therapies

Fluticasone is often combined with other medications to provide enhanced treatment for asthma and allergies. Common combinations include:

  • Fluticasone + Salmeterol: Known by brand names such as Seretide or Advair, this combination provides both anti-inflammatory and long-acting bronchodilator effects for asthma treatment[5]
  • Fluticasone + Azelastine: Used in nasal sprays for allergic rhinitis, combining the anti-inflammatory effects of fluticasone with the antihistamine properties of azelastine[4]

These combination therapies can offer more comprehensive symptom relief for patients with moderate to severe asthma or allergies.

Effectiveness of Fluticasone

Clinical studies have shown that fluticasone is effective in managing asthma and allergic rhinitis symptoms. Some key findings include:

  • Improved lung function, as measured by Forced Expiratory Volume in 1 second (FEV1), which is the amount of air a person can forcefully exhale in one second[6]
  • Reduction in asthma symptoms and decreased need for rescue medications[3]
  • Better control of nasal allergy symptoms, including sneezing, runny nose, and congestion[7]

The effectiveness of fluticasone can be assessed using various measures, including pulmonary function tests, symptom scores, and quality of life questionnaires.

Potential Side Effects

While fluticasone is generally well-tolerated, it may cause some side effects. Common side effects include:

  • Nasal irritation or dryness (when used as a nasal spray)
  • Throat irritation or hoarseness (when used as an inhaler)
  • Headache
  • Nosebleeds (epistaxis)

In rare cases, more serious side effects may occur, such as:

  • Increased risk of infections, particularly in the mouth, throat, or lungs
  • Changes in vision or eye problems (e.g., glaucoma or cataracts)
  • Slowed growth in children (with long-term use)

It’s important to discuss any concerns about side effects with your healthcare provider[3].

Ongoing Clinical Studies

Researchers continue to study fluticasone to better understand its effects and potential new applications. Some ongoing areas of research include:

  • Comparing the effectiveness of different fluticasone formulations and delivery methods[1]
  • Investigating the long-term safety and efficacy of fluticasone in various patient populations[6]
  • Exploring new combination therapies that include fluticasone for enhanced treatment of respiratory conditions[4]

These studies aim to improve our understanding of fluticasone and optimize its use in treating asthma, allergies, and other respiratory disorders.

Aspect Details
Study Types Randomized controlled trials, post-marketing surveillance, bioavailability studies
Conditions Studied Asthma (mild to severe), Seasonal Allergic Rhinitis, Chronic Obstructive Pulmonary Disease (COPD)
Fluticasone Formulations Fluticasone furoate (Arnuity Ellipta), Fluticasone propionate (Flovent, Flonase), Combinations (Seretide, Flutiform)
Administration Routes Inhalers (pMDI, DPI), Nasal sprays
Primary Outcomes Lung function (FEV1, FVC), Symptom scores, Exacerbation rates, Safety profiles
Secondary Outcomes Quality of life measures, Bronchial hyperresponsiveness, Imaging results (CT, MRI)
Patient Populations Adults, Adolescents, Children (5-12 years)
Comparators Other corticosteroids, Combination therapies, Placebos
Study Durations Range from 2 weeks to 18 months
Safety Assessments Adverse events, Laboratory tests, Vital signs, Cortisol levels

FAQ

  • What conditions are being studied in these fluticasone trials? The clinical trials are primarily studying the use of fluticasone in treating asthma and seasonal allergic rhinitis. Some trials focus on mild to moderate asthma, while others look at moderate to severe persistent asthma.
  • What are some of the different fluticasone formulations being tested? Various formulations are being studied, including fluticasone furoate (Arnuity Ellipta), fluticasone propionate (Flovent, Flonase), and combinations like fluticasone/salmeterol (Seretide) and fluticasone/formoterol (Flutiform). These come in different forms such as inhalers, nasal sprays, and dry powder inhalers.
  • How is the effectiveness of fluticasone being measured in these trials? Effectiveness is being measured through various means, including lung function tests (like FEV1 and FVC), symptom scores, quality of life questionnaires, frequency of exacerbations, and in some cases, advanced imaging techniques like hyperpolarized xenon-129 MRI.
  • Are there any trials comparing fluticasone to other medications? Yes, several trials are comparing fluticasone to other treatments. For example, one study compares Flutiform to Fluticasone and Seretide in pediatric asthma patients. Another compares a generic fluticasone nasal spray to the brand-name Flonase for allergic rhinitis.
  • What age groups are included in these fluticasone trials? The trials include both adult and pediatric patients. Some studies focus specifically on children aged 5 to less than 12 years with asthma, while others include adolescents and adults with various respiratory conditions.

Ongoing Clinical Trials on Fluticasone

  • Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Greece Hungary Italy +3

Glossary

  • Fluticasone: A corticosteroid medication used to treat asthma and allergic rhinitis by reducing inflammation in the airways and nasal passages.
  • FEV1: Forced Expiratory Volume in 1 second, a measure of how much air a person can exhale in one second. It's used to assess lung function and the severity of respiratory diseases.
  • Inhaled Corticosteroids (ICS): A class of medications that are inhaled directly into the lungs to reduce inflammation and prevent asthma symptoms.
  • Bronchial Asthma: A chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties.
  • Exacerbation: A worsening of symptoms or an acute episode in a chronic disease, such as asthma.
  • Bioavailability: The extent and rate at which a drug enters the body's circulation and becomes available at the site of action.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the active drug being tested.
  • Randomized Controlled Trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare the effects of different interventions.
  • Hyperpolarized Xenon-129 MRI: An advanced imaging technique used to visualize lung function and gas exchange in detail.
  • Adverse Event (AE): Any unfavorable and unintended sign, symptom, or disease that occurs during the use of a medical treatment, regardless of whether it is considered related to the treatment.

References

  1. https://clinicaltrials.gov/study/NCT02266927
  2. https://clinicaltrials.gov/study/NCT03184480
  3. https://clinicaltrials.gov/study/NCT00843193
  4. https://clinicaltrials.gov/study/NCT06180083
  5. https://clinicaltrials.gov/study/NCT01202097
  6. https://clinicaltrials.gov/study/NCT03595930
  7. https://clinicaltrials.gov/study/NCT02238353